FORWARD VENTURES
Forward Ventures, founded in 1993, is a leading life-science venture capital firm located in San Diego. Forward has a team of investment professionals with extensive experience in entrepreneurship, venture capital and operations. Our firm has invested in over 50 companies since it was founded in 1993 and currently has more than $500 million in capital under management. The most recent fund, Forward V, continues Forward Ventures’ program of life sciences and health care venture investing in companies of all stages of development. Forward invests throughout the United States and will consider select European opportunities.
FORWARD VENTURES
Social Links:
Industry:
Financial Services
Founded:
1993-01-01
Status:
Active
Contact:
858-677-6077
Email Addresses:
[email protected]
Technology used in webpage:
SPF Google Font API LetsEncrypt Content Delivery Network Apache Microsoft Exchange Online Amazon Office 365 Mail Google Maps AJAX Libraries API
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-08-20 | Virtuoso | Forward Ventures investment in Seed Round - Virtuoso | 3.25 M USD |
| 2017-04-04 | Viracta Therapeutics | Forward Ventures investment in Series B - Viracta Therapeutics | 18.4 M USD |
| 2015-08-24 | Syndax Pharmaceuticals | Forward Ventures investment in Series C - Syndax Pharmaceuticals | 80 M USD |
| 2013-09-11 | Affinium Pharmaceuticals | Forward Ventures investment in Debt Financing - Affinium Pharmaceuticals | 11.9 M USD |
| 2013-08-27 | Syndax Pharmaceuticals | Forward Ventures investment in Series B - Syndax Pharmaceuticals | 26.6 M USD |
| 2012-11-06 | Ambit Biosciences | Forward Ventures investment in Venture Round - Ambit Biosciences | 50 M USD |
| 2012-03-12 | Viracta Therapeutics | Forward Ventures investment in Series B - Viracta Therapeutics | 13 M USD |
| 2011-08-29 | Affinium Pharmaceuticals | Forward Ventures investment in Series B - Affinium Pharmaceuticals | 15 M USD |
| 2011-06-10 | Ambit Biosciences | Forward Ventures investment in Series D - Ambit Biosciences | 30 M USD |
| 2010-06-25 | Nereus Pharmaceuticals | Forward Ventures investment in Series E - Nereus Pharmaceuticals | 20 M USD |